Robert Negrin

BMT specialist, Hematologist

Professor of Medicine (Blood and Marrow Transplantation)

Blood and Marrow Transplant Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-723-0822
Learn More About the Clinic Getting Here Make An Appointment

Hematology Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Residency: Stanford University School of Medicine (1986) CA

Internship: Stanford University School of Medicine (1985) CA

Fellowship: Stanford University School of Medicine (1987) CA

Board Certification: Hematology, American Board of Internal Medicine (1992)

Board Certification: Internal Medicine, American Board of Internal Medicine (1987)

Medical Education: Harvard Medical School (1984) MA

BA, Univ. California, Berkeley, Biochemistry (1977)

Honors & Awards

Fellowship, Damon Runyon-Walter Winchell Cancer Fund (1988-1991)

Fellow, Jose Carreras International Leukemia Foundation (1993-1996)

President, International Society of Cellular Therapy (2000-2002)

Distinguished Clinical Scientist Award, Doris Duke Foundation (2004-2009)

President, American Society of Blood and Marrow Transplantation (2006-2007)

Member, Association of American Physicians (AAP) (2008)

Associate Editor, Blood (2010-present)

Administrative Appointments

Medical Director, Clinical Bone Marrow Transplantation Laboratory (1990 - Present)

Division Chief, Blood and Marrow Transplant Program, Stanford University (2000 - Present)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Total Lymphoid Irradiation-Antithymocyte Globulin Conditioning and Allogeneic Transplantation for Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms
Benjamin, J., Chhabra, S., Kohrt, H. E., Lavori, P., Laport, G. G., & Lowsky, R. (2014). Total Lymphoid Irradiation-Antithymocyte Globulin Conditioning and Allogeneic Transplantation for Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(6), 837-843.

Donor hematopoiesis in mice following total lymphoid irradiation requires host T-regulatory cells for durable engraftment.
Müller, A. Ms., Poyser, J., Küpper, N. J., Burnett, C., Ko, R. M., & Shizuru, J. A. (2014). Donor hematopoiesis in mice following total lymphoid irradiation requires host T-regulatory cells for durable engraftment. Blood, 123(18), 2882-2892.

Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.
Giralt, S., Costa, L., Schriber, J., DiPersio, J., Maziarz, R., & Devine, S. (2014). Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations. Biology of blood and marrow transplantation , 20(3), 295-308.

Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation.
Sega, E. I., Leveson-Gower, D. B., Florek, M., Schneidawind, D., Luong, R. H., & Negrin, R. S. (2014). Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation. PloS one, 9(1).

Mast cells suppress murine GVHD in a mechanism independent of CD4(+)CD25(+) regulatory T cells
Leveson-Gower, D. B., Sega, E. I., Kalesnikoff, J., Florek, M., Pan, Y., & Negrin, R. S. (2013). Mast cells suppress murine GVHD in a mechanism independent of CD4(+)CD25(+) regulatory T cells. BLOOD, 122(22), 3659-3665.

IL-17 gene ablation does not impact Treg-mediated suppression of graft-versus-host disease after bone marrow transplantation.
Colonna, L., Florek, M., Leveson-Gower, D. B., Sega, E. I., Baker, J., & Negrin, R. S. (2013). IL-17 gene ablation does not impact Treg-mediated suppression of graft-versus-host disease after bone marrow transplantation. Biology of blood and marrow transplantation , 19(11), 1557-1565.

Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation.
Schneidawind, D., Pierini, A., & Negrin, R. S. (2013). Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation. Blood, 122(18), 3116-3121.

A distinct evolution of the T-cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host disease
Meyer, E. H., Hsu, A. R., Liliental, J., Loehr, A., Florek, M., & Negrin, R. S. (2013). A distinct evolution of the T-cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host disease. BLOOD, 121(24), 4955-4962.

A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model
Baeuerlein, C. A., Riedel, S. S., Baker, J., Brede, C., Garrote, A.-L. J., & Beilhack, A. (2013). A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model. BMC MEDICINE, 11.

A new approach for eradication of residual lymphoma cells by host nonreactive anti-third-party central memory CD8 T cells.
Lask, A., Ophir, E., Or-Geva, N., Cohen-Fredarow, A., Afik, R., & Reisner, Y. (2013). A new approach for eradication of residual lymphoma cells by host nonreactive anti-third-party central memory CD8 T cells. Blood, 121(15), 3033-3040.

Murine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells.
Ophir, E., Or-Geva, N., Gurevich, I., Tal, O., Eidelstein, Y., & Reisner, Y. (2013). Murine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells. Blood, 121(7), 1220-1228.

A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model.
Bäuerlein, C. A., Riedel, S. S., Baker, J., Brede, C., Garrote, A.-L. J., & Beilhack, A. (2013). A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model. BMC medicine, 11, 134-?.

Cancer Vaccines and T Cell Therapy
Rezvani, K., Brody, J. D., Kohrt, H. E., Logan, A. C., Advani, R., & Barrett, J. (2013). Cancer Vaccines and T Cell Therapy. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19(1), S97-S101.

Mapping immune processes in intact tissues at cellular resolution.
Brede, C., Friedrich, M., Jordán-Garrote, A.-L., Riedel, S. S., Bäuerlein, C. A., & Beilhack, A. (2012). Mapping immune processes in intact tissues at cellular resolution. journal of clinical investigation, 122(12), 4439-4446.

Mapping immune processes in intact tissues at cellular resolution
Brede, C., Friedrich, M., Jordan-Garrote, A.-L., Riedel, S. S., Baeuerlein, C. A., & Beilhack, A. (2012). Mapping immune processes in intact tissues at cellular resolution. JOURNAL OF CLINICAL INVESTIGATION, 122(12), 4439-4446.

Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
Arai, S., Sahaf, B., Narasimhan, B., Chen, G. L., Jones, C. D., & Miklos, D. B. (2012). Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence. BLOOD, 119(25), 6145-6154.

Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells
Gill, S., Vasey, A. E., De Souza, A., Baker, J., Smith, A. T., & Negrin, R. S. (2012). Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells. BLOOD, 119(24), 5758-5768.

Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity
Mueller, A. Ms., Shashidhar, S., Kuepper, N. J., Kohrt, H. Ek., Florek, M., & Shizuru, J. A. (2012). Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(15), 5820-5825.

Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation
Johnston, L., Florek, M., Armstrong, R., McCune, J. S., Arai, S., & Negrin, R. (2012). Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation. BONE MARROW TRANSPLANTATION, 47(4), 581-588.

Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma
Chen, A. I., Negrin, R. S., McMillan, A., Shizuru, J. A., JOHNSTON, L. J., & Stockerl-Goldstein, K. (2012). Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma. BONE MARROW TRANSPLANTATION, 47(4), 516-521.

Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow
Mielcarek, M., Storer, B., Martin, P. J., Forman, S. J., Negrin, R. S., & Bensinger, W. I. (2012). Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow. BLOOD, 119(11), 2675-2678.

Cytomegalovirus Viral Load and Virus-Specific Immune Reconstitution after Peripheral Blood Stem Cell versus Bone Marrow Transplantation
Guerrero, A., Riddell, S. R., Storek, J., Stevens-Ayers, T., Storer, B., & Boeckh, M. (2012). Cytomegalovirus Viral Load and Virus-Specific Immune Reconstitution after Peripheral Blood Stem Cell versus Bone Marrow Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 18(1), 66-75.

Long-Term Outcome of Patients with Metastatic Breast Cancer Treated with High-Dose Chemotherapy and Transplantation of Purified Autologous Hematopoietic Stem Cells
Mueller, A. Ms., Kohrt, H. Ek., Cha, S., Laport, G., Klein, J., & Shizuru, J. A. (2012). Long-Term Outcome of Patients with Metastatic Breast Cancer Treated with High-Dose Chemotherapy and Transplantation of Purified Autologous Hematopoietic Stem Cells. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 18(1), 125-133.

Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation
Laport, G. G., Sheehan, K., Baker, J., Armstrong, R., Wong, R. M., & Negrin, R. S. (2011). Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 17(11), 1679-1687.

Role of regulatory T cell populations in controlling graft vs host disease
Negrin, R. S. (2011). Role of regulatory T cell populations in controlling graft vs host disease. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 24(3), 453-457.

Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4(+)CD25(+)Foxp3(+) regulatory T cells
Shin, H.-J., Baker, J., Leveson-Gower, D. B., Smith, A. T., Sega, E. I., & Negrin, R. S. (2011). Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4(+)CD25(+)Foxp3(+) regulatory T cells. BLOOD, 118(8), 2342-2350.

Autologous versus Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin Lymphoma beyond First Complete Response or First Partial Response
Tomblyn, M. R., Ewell, M., Bredeson, C., Kahl, B. S., Goodman, S. A., & Laport, G. G. (2011). Autologous versus Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin Lymphoma beyond First Complete Response or First Partial Response. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 17(7), 1051-1057.

Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism
Leveson-Gower, D. B., Olson, J. A., Sega, E. I., Luong, R. H., Baker, J., & Negrin, R. S. (2011). Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism. BLOOD, 117(11), 3220-3229.

CD8(+)CD44(hi) but not CD4(+)CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD
Dutt, S., Baker, J., Kohrt, H. E., Kambham, N., Sanyal, M., & Strober, S. (2011). CD8(+)CD44(hi) but not CD4(+)CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHD. BLOOD, 117(11), 3230-3239.

Short-Term Immunosuppression Promotes Engraftment of Embryonic and Induced Pluripotent Stem Cells
Pearl, J. I., Lee, A. S., Leveson-Gower, D. B., Sun, N., Ghosh, Z., & Wu, J. C. (2011). Short-Term Immunosuppression Promotes Engraftment of Embryonic and Induced Pluripotent Stem Cells. CELL STEM CELL, 8(3), 309-317.

Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY
Naik, S., Wong, R., Arai, S., Brown, J., Laport, G., & Johnston, L. (2011). Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY. BONE MARROW TRANSPLANTATION, 46(2), 192-199.

Natural and Expanded CD4(+) CD25(+) Regulatory T Cells in Bone Marrow Transplantation
Colonna, L., Sega, E. I., & Negrin, R. S. (2011). Natural and Expanded CD4(+) CD25(+) Regulatory T Cells in Bone Marrow Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 17(1), S58-S62.

CXCL12 Mediates Immunosuppression in the Lymphoma Microenvironment after Allogeneic Transplantation of Hematopoietic Cells
Duerr, C., Pfeifer, D., Claus, R., Schmitt-Graeff, A., Gerlach, U. V., & Zeiser, R. (2010). CXCL12 Mediates Immunosuppression in the Lymphoma Microenvironment after Allogeneic Transplantation of Hematopoietic Cells. CANCER RESEARCH, 70(24), 10170-10181.

Definition of an Enhanced Immune Cell Therapy in Mice That Can Target Stem-Like Lymphoma Cells
Contag, C. H., Sikorski, R., Negrin, R. S., Schmidt, T., Fan, A. C., & Thorne, S. H. (2010). Definition of an Enhanced Immune Cell Therapy in Mice That Can Target Stem-Like Lymphoma Cells. CANCER RESEARCH, 70(23), 9837-9845.

Phase I/II Trial of GN-BVC, a Gemcitabine and Vinorelbine-Containing Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Recurrent and Refractory Hodgkin Lymphoma
Arai, S., Letsinger, R., Wong, R. M., Johnston, L. J., Laport, G. G., & Horning, S. J. (2010). Phase I/II Trial of GN-BVC, a Gemcitabine and Vinorelbine-Containing Conditioning Regimen for Autologous Hematopoietic Cell Transplantation in Recurrent and Refractory Hodgkin Lymphoma. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 16(8), 1145-1154.

CD11B+CD11C+DENDRITIC CELLS INTERACT WITH ALLOREACTIVE T CELLS IN THE INTESTINAL MUCOSA IN ACUTE GRAFT-VERSUS-HOST DISEASE
Garrote, A. Lj., Brede, C., Baeuerlein, C., Riedel, S., Kiesel, C., & Schulz, S. (2010). CD11B+CD11C+DENDRITIC CELLS INTERACT WITH ALLOREACTIVE T CELLS IN THE INTESTINAL MUCOSA IN ACUTE GRAFT-VERSUS-HOST DISEASE. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 95, 480-480.

DIFFERENCES IN ALLOREACTIVE T CELL MIGRATION IN MHC MATCHED VERSUS MHC MISMATCHED HCT ARE CAUSED BY WAVES OF T CELL EXPANSION
Baeuerlein, C., Riedel, S., Brede, C., Garrote, A. Lj., Kiesel, C., & Beilhack, A. (2010). DIFFERENCES IN ALLOREACTIVE T CELL MIGRATION IN MHC MATCHED VERSUS MHC MISMATCHED HCT ARE CAUSED BY WAVES OF T CELL EXPANSION. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 95, 479-479.

NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
Olson, J. A., Leveson-Gower, D. B., Gill, S., Baker, J., Beilhack, A., & Negrin, R. S. (2010). NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects. BLOOD, 115(21), 4293-4301.

Simultaneous blockade of several endothelial ligands is required to prevent alloreactive T-cell trafficking to target tissues
Beilhack, A., Baker, J., Riedel, S., Brede, C., Baeuerlein, C. A., & Schulz, S. (2010). Simultaneous blockade of several endothelial ligands is required to prevent alloreactive T-cell trafficking to target tissues. BONE MARROW TRANSPLANTATION, 45, S15-S15.

Biology and clinical effects of natural killer cells in allogeneic transplantation
Benjamin, J. E., Gill, S., & Negrin, R. S. (2010). Biology and clinical effects of natural killer cells in allogeneic transplantation. CURRENT OPINION IN ONCOLOGY, 22(2), 130-137.

Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged autografts after induction failure
Benjamin, J. E., Chen, G. L., Cao, T. M., Cao, P. D., Wong, R. M., & Laport, G. G. (2010). Long-term follow-up of patients with diffuse large B-cell non-Hodgkin's lymphoma receiving purged autografts after induction failure. BONE MARROW TRANSPLANTATION, 45(2), 303-309.

Immunoglobulin G Fc Receptor Fc gamma RIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma
Weng, W.-K., Negrin, R. S., Lavori, P., & Horning, S. J. (2010). Immunoglobulin G Fc Receptor Fc gamma RIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 28(2), 279-284.

Direct Imaging of Immune Rejection and Memory Induction by Allogeneic Mesenchymal Stromal Cells
Zangi, L., Margalit, R., Reich-Zeliger, S., Bachar-Lustig, E., Beilhack, A., & Reisner, Y. (2009). Direct Imaging of Immune Rejection and Memory Induction by Allogeneic Mesenchymal Stromal Cells. STEM CELLS, 27(11), 2865-2874.

Tissue-Specific Homing and Expansion of Donor NK Cells in Allogeneic Bone Marrow Transplantation
Olson, J. A., Zeiser, R., Beilhack, A., Goldman, J. J., & Negrin, R. S. (2009). Tissue-Specific Homing and Expansion of Donor NK Cells in Allogeneic Bone Marrow Transplantation. JOURNAL OF IMMUNOLOGY, 183(5), 3219-3228.

TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors
Kohrt, H. E., Turnbull, B. B., Heydari, K., Shizuru, J. A., Laport, G. G., & Lowsky, R. (2009). TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. BLOOD, 114(5), 1099-1109.

Natural Killer Cells in Allogeneic Transplantation: Effect on Engraftment, Graft- versus-Tumor, and Graft-versus-Host Responses
Gill, S., Olson, J. A., & Negrin, R. S. (2009). Natural Killer Cells in Allogeneic Transplantation: Effect on Engraftment, Graft- versus-Tumor, and Graft-versus-Host Responses. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 15(7), 765-776.

Regulation of different inflammatory diseases by impacting the mevalonate pathway
Zeiser, R., Maas, K., Youssef, S., Duerr, C., Steinman, L., & Negrin, R. S. (2009). Regulation of different inflammatory diseases by impacting the mevalonate pathway. IMMUNOLOGY, 127(1), 18-25.

Glycogen synthase kinase 3 beta missplicing contributes to leukemia stem cell generation
Abrahamsson, A. E., Geron, I., Gotlib, J., Dao, K.-H. T., Barroga, C. F., & Jamieson, C. Hm. (2009). Glycogen synthase kinase 3 beta missplicing contributes to leukemia stem cell generation. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 106(10), 3925-3929.

Follicular lymphoma B cells induce the conversion of conventional CD4(+) T cells to T-regulatory cells
Ai, W. Z., Hou, L.-Z., Zeiser, R., Czerwinski, D., Negrin, R. S., & Levy, R. (2009). Follicular lymphoma B cells induce the conversion of conventional CD4(+) T cells to T-regulatory cells. INTERNATIONAL JOURNAL OF CANCER, 124(1), 239-244.

Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation
Reichardt, W., Duerr, C., von Elverfeldt, D., Juettner, E., Gerlach, U. V., & Zeiser, R. (2008). Impact of mammalian target of rapamycin inhibition on lymphoid homing and tolerogenic function of nanoparticle-labeled dendritic cells following allogeneic hematopoietic cell transplantation. JOURNAL OF IMMUNOLOGY, 181(7), 4770-4779.

In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity
Nishimura, R., Baker, J., Beilhack, A., Zeiser, R., Olson, J. A., & Negrin, R. S. (2008). In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity. BLOOD, 112(6), 2563-2574.

Plasmacytoid dendritic cells take up opsonized antigen leading to CD4(+) and CD8(+) T cell activation in vivo
Bjorck, P., Beilhack, A., Herman, E. I., Negrin, R. S., & Engleman, E. G. (2008). Plasmacytoid dendritic cells take up opsonized antigen leading to CD4(+) and CD8(+) T cell activation in vivo. JOURNAL OF IMMUNOLOGY, 181(6), 3811-3817.

Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen
Laport, G. G., Alvarnas, J. C., Palmer, J. M., Snyder, D. S., Slovak, M. L., & Forman, S. J. (2008). Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen. BLOOD, 112(3), 903-909.

Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: The Stanford experience
Chen, A. I., McMillan, A., Neprin, R. S., Horning, S. J., & Laport, G. G. (2008). Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: The Stanford experience. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 14(7), 741-747.

Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs
Beilhack, A., Schulz, S., Baker, J., Beilhack, G. F., Nishimura, R., & Negrin, R. S. (2008). Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. BLOOD, 111(5), 2919-2928.

Interleukin-2 receptor downstream events in regulatory T cells - Implications for the choice of immunosuppressive drug therapy
Zeiser, R., & Negrin, R. S. (2008). Interleukin-2 receptor downstream events in regulatory T cells - Implications for the choice of immunosuppressive drug therapy. CELL CYCLE, 7(4), 458-462.

The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation
Nguyen, V. H., Shashidhar, S., Chang, D. S., Ho, L., Kambham, N., & Negrin, R. S. (2008). The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. BLOOD, 111(2), 945-953.

Differential impact of mammalian target of rapamycin inhibition on CD4(+)CD25(+)Foxp3(+) regulatory T cells compared with conventional CD4(+) T cells
Zeiser, R., Leveson-Gower, D. B., Zambricki, E. A., Kambham, N., Beilhack, A., & Negrin, R. S. (2008). Differential impact of mammalian target of rapamycin inhibition on CD4(+)CD25(+)Foxp3(+) regulatory T cells compared with conventional CD4(+) T cells. BLOOD, 111(1), 453-462.

Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity
Zeiser, R., Youssef, S., Baker, J., Kambham, N., Steinman, L., & Negrin, R. S. (2007). Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity. BLOOD, 110(13), 4588-4598.

Host-derived interleukin-18 differentially impacts regulatory and conventional T cell expansion during acute graft-versus-host disease
Zeiser, R., Zambricki, E. A., Leveson-Gower, D., Kambham, N., Beilhack, A., & Negrin, R. S. (2007). Host-derived interleukin-18 differentially impacts regulatory and conventional T cell expansion during acute graft-versus-host disease. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 13(12), 1427-1438.

A novel technique for the enrichment of primary ovarian cancer cells
Chan, J. K., Hamilton, C. A., Anderson, E. M., Cheung, M. K., Baker, J., & Negrin, R. S. (2007). A novel technique for the enrichment of primary ovarian cancer cells. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 197(5).

CD101 surface expression discriminates potency among murine FoxP3(+) regulatory T cells
Fernandez, I., Zeiser, R., Karsunky, H., Kambham, N., Beilhack, A., & Engleman, E. (2007). CD101 surface expression discriminates potency among murine FoxP3(+) regulatory T cells. JOURNAL OF IMMUNOLOGY, 179(5), 2808-2814.

In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation
Nguyen, V. H., Zeiser, R., daSilva, D. L., Chang, D. S., Beilhack, A., & Negrin, R. S. (2007). In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. BLOOD, 109(6), 2649-2656.

Early CD30 signaling is critical for adoptively transferred CD4(+)CD25(+) regulatory T cells in prevention of acute graft-versus-host disease
Zeiser, R., Nguyen, V. H., Hou, J.-Z., Beilhack, A., Zambricki, E., & Negrin, R. S. (2007). Early CD30 signaling is critical for adoptively transferred CD4(+)CD25(+) regulatory T cells in prevention of acute graft-versus-host disease. BLOOD, 109(5), 2225-2233.

The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia
Oehler, V. G., Gooley, T., Snyder, D. S., Johnston, L., Lin, A., & Radich, J. P. (2007). The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia. BLOOD, 109(4), 1782-1789.

Promise and challenges of human regulatory T cells in the clinic
Negrin, R. S., & Hou, J.-Z. (2007). Promise and challenges of human regulatory T cells in the clinic. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 13(1), 12-16.

Role of naturally arising regulatory T cells in hematopoietic cell transplantation
Nguyen, V. H., Zeiser, R., & Negrin, R. S. (2006). Role of naturally arising regulatory T cells in hematopoietic cell transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 12(10), 995-1009.

High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma
Law, L. Y., Horning, S. J., Wong, R. M., Johnston, L. J., Laport, G. G., & Stockerl-Goldstein, K. E. (2006). High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 12(7), 703-711.

Inhibition of CD4(+)CD25(+) regulatory T-cell function by calcineurin-dependent interleukin-2 production
Zeiser, R., Nguyen, V. H., Beilhack, A., Buess, M., Schulz, S., & Negrin, R. S. (2006). Inhibition of CD4(+)CD25(+) regulatory T-cell function by calcineurin-dependent interleukin-2 production. BLOOD, 108(1), 390-399.

In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease.
Negrin, R. S., & Contag, C. H. (2006). In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease. Nature reviews. Immunology, 6(6), 484-490.

Innovation - In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease
Negrin, R. S., & Contag, C. H. (2006). Innovation - In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease. NATURE REVIEWS IMMUNOLOGY, 6(6), 484-U2.

Acute graft-versus-host disease-challenge for a broader application of allogeneic hematopoietic cell transplantation.
Zeiser, R., Beilhack, A., & Negrin, R. S. (2006). Acute graft-versus-host disease-challenge for a broader application of allogeneic hematopoietic cell transplantation. Current stem cell research & therapy, 1(2), 203-212.

Synergistic antitumor effects of immune cell-viral biotherapy
Thorne, S. H., Negrin, R. S., & Contag, C. H. (2006). Synergistic antitumor effects of immune cell-viral biotherapy. SCIENCE, 311(5768), 1780-1784.

Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: A preclinical study
Chan, J. K., Hamilton, C. A., Cheung, M. K., Karimi, M., Baker, J., & Negrin, R. S. (2006). Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: A preclinical study. CLINICAL CANCER RESEARCH, 12(6), 1859-1867.

The apoptotic and proliferative fate of cytokine-induced killer cells after redirection to tumor cells with bispecific Ab
Kornacker, M., Verneris, M. R., Kornacker, B., Ganten, T. M., Scheffold, C., & Negrin, R. S. (2006). The apoptotic and proliferative fate of cytokine-induced killer cells after redirection to tumor cells with bispecific Ab. CYTOTHERAPY, 8(1), 13-23.

Total lymphoid irradiation and transplantation tolerance
Lowsky, R., & Negrin, R. S. (2006). Total lymphoid irradiation and transplantation tolerance. CURRENT OPINION IN ORGAN TRANSPLANTATION, 11(1), 54-61.

Protective conditioning for acute graft-versus-host disease - Reply
Lowsky, R., Negrin, R. S., & Strober, S. (2005). Protective conditioning for acute graft-versus-host disease - Reply. NEW ENGLAND JOURNAL OF MEDICINE, 353(25), 2718-2718.

Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8(+) T cells and NK cells
Karimi, M., Cao, T. M., Baker, J. A., Verneris, M. R., Soares, L., & Negrin, R. S. (2005). Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8(+) T cells and NK cells. JOURNAL OF IMMUNOLOGY, 175(12), 7819-7828.

Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation
Schimmelpfennig, C. H., Schulz, S., Arber, C., Baker, J., Tarner, I., & Negrin, R. S. (2005). Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation. AMERICAN JOURNAL OF PATHOLOGY, 167(5), 1321-1331.

Protective conditioning for acute graft-versus-host disease
Lowsky, R., Takahashi, T., Liu, Y. P., Dejbakhsh-Jones, S., GRUMET, F. C., & Strober, S. (2005). Protective conditioning for acute graft-versus-host disease. NEW ENGLAND JOURNAL OF MEDICINE, 353(13), 1321-1331.

In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets
Beilhack, A., Schulz, S., Baker, J., Beilhack, G. F., Wieland, C. B., & Negrin, R. S. (2005). In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. BLOOD, 106(3), 1113-1122.

Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation
Cao, Y. A., Bachmann, M. H., Beilhack, A., Yang, Y., Tanaka, M., & Contag, C. H. (2005). Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation. TRANSPLANTATION, 80(1), 134-139.

Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells
Verneris, M. R., Arshi, A., Edinger, M., Kornacker, M., Natkunam, Y., & Negrin, R. S. (2005). Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells. CLINICAL CANCER RESEARCH, 11(12), 4561-4570.

A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma
Leemhuis, T., Wells, S., Scheffold, C., Edinger, M., & Negrin, R. S. (2005). A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 11(3), 181-187.

Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia
Oehler, V. G., Radich, J. P., Storer, I., Blume, K. G., Chauncey, T., & Bensinger, W. (2005). Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 11(2), 85-92.

Hematopoietic stem and progenitor cells: Clinical and preclinical regeneration of the hematolymphoid system
Shizuru, J. A., Negrin, R. S., & Weissman, I. L. (2005). Hematopoietic stem and progenitor cells: Clinical and preclinical regeneration of the hematolymphoid system. ANNUAL REVIEW OF MEDICINE, 56, 509-538.

Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8(+) T cells
Verneris, M. R., Karami, M., Baker, J., Jayaswal, A., & Negrin, R. S. (2004). Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8(+) T cells. BLOOD, 103(8), 3065-3072.

Evaluation of effector cell fate and function by in vivo bioluminescence imaging
Edinger, M., Hoffmann, P., Contag, C. H., & Negrin, R. S. (2003). Evaluation of effector cell fate and function by in vivo bioluminescence imaging. METHODS, 31(2), 172-179.

CD4(+)CD25(+) regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
Edinger, M., Hoffmann, P., Ermann, J., Drago, K., Fathman, C. G., & Negrin, R. S. (2003). CD4(+)CD25(+) regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. NATURE MEDICINE, 9(9), 1144-1150.

Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging
Edinger, M., Cao, Y. A., Verneris, M. R., Bachmann, M. H., Contag, C. H., & Negrin, R. S. (2003). Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. BLOOD, 101(2), 640-648.

Advancing animal models of neoplasia through in vivo bioluminescence imaging
Edinger, M., Cao, Y. A., Hornig, Y. S., Jenkins, D. E., Verneris, M. R., & Contag, C. H. (2002). Advancing animal models of neoplasia through in vivo bioluminescence imaging. EUROPEAN JOURNAL OF CANCER, 38(16), 2128-2136.

Visualization of effective tumor targeting by CD8+natural killer T cells redirected with bispecific antibody F(ab ')(2)HER2xCD3
Scheffold, C., Kornacker, M., Scheffold, Y. C., Contag, C. H., & Negrin, R. S. (2002). Visualization of effective tumor targeting by CD8+natural killer T cells redirected with bispecific antibody F(ab ')(2)HER2xCD3. CANCER RESEARCH, 62(20), 5785-5791.

Studies of ex vivo activated and expanded CD8(+) NK-T cells in humans and mice
Verneris, M. R., Baker, J., Edinger, M., & Negrin, R. S. (2002). Studies of ex vivo activated and expanded CD8(+) NK-T cells in humans and mice. JOURNAL OF CLINICAL IMMUNOLOGY, 22(3), 131-136.

Understanding immune cell trafficking patterns via in vivo bioluminescence imaging
Mandl, S., Schimmelpfennig, C., Edinger, M., Negrin, R. S., & Contag, C. H. (2002). Understanding immune cell trafficking patterns via in vivo bioluminescence imaging. JOURNAL OF CELLULAR BIOCHEMISTRY, 239-248.

Visualization of tumor growth and response to NK-T cell based immunotherapy using bioluminescence
Negrin, R. S., Edinger, M., Verneris, M., Cao, Y. A., Bachmann, M., & Contag, C. H. (2002). Visualization of tumor growth and response to NK-T cell based immunotherapy using bioluminescence. ANNALS OF HEMATOLOGY, 81, S44-S45.

Bioluminescence imaging of lymphocyte trafficking in vivo
Hardy, J., Edinger, M., Bachmann, M. H., Negrin, R. S., Fathman, C. G., & Contag, C. H. (2001). Bioluminescence imaging of lymphocyte trafficking in vivo. EXPERIMENTAL HEMATOLOGY, 29(12), 1353-1360.

Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis
Kornacker, M., Schlattner, U., Wallimann, T., Verneris, M. R., Negrin, R. S., & Wolf, J. (2001). Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis. INTERNATIONAL JOURNAL OF CANCER, 94(4), 513-519.

Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+cells in patients with advanced hematologic malignancies
Cao, T. M., Kusnierz-Glaz, C., Valone, F., Stockerl-Goldstein, K. E., Hu, W. W., & Negrin, R. S. (2001). Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+cells in patients with advanced hematologic malignancies. CANCER, 91(12), 2205-2213.

Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production
Baker, J., Verneris, M. R., Ito, M., Shizuru, J. A., & Negrin, R. S. (2001). Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production. BLOOD, 97(10), 2923-2931.

Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells
Kornacker, M., Verneris, M. R., Kornacker, B., Scheffold, C., & Negrin, R. S. (2001). Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells. IMMUNOLOGY LETTERS, 76(3), 169-173.

CD58/LFA-3 and IL-12 provided by activated monocytes are critical in the in vitro expansion of CD56(+) T cells
Lopez, R. D., Waller, E. K., Lu, P. H., & Negrin, R. S. (2001). CD58/LFA-3 and IL-12 provided by activated monocytes are critical in the in vitro expansion of CD56(+) T cells. CANCER IMMUNOLOGY IMMUNOTHERAPY, 49(12), 629-640.

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
Bensinger, W. I., Martin, P. J., Storer, B., Clift, R., Forman, S. J., & Blume, K. (2001). Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. NEW ENGLAND JOURNAL OF MEDICINE, 344(3), 175-181.

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial
Horning, S. J., Negrin, R. S., Hoppe, R. T., Rosenberg, S. A., Chao, N. J., & Blume, K. G. (2001). High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. BLOOD, 97(2), 404-409.

High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: The Stanford University experience
Cao, T. M., Horning, S. F., Negrin, R. S., Hu, W. W., Johnston, L. F., & Stockerl-Goldstein, K. (2001). High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: The Stanford University experience. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 7(5), 294-301.

Expansion of cytotoxic CD3(+)CD56(+) cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation
Alvarnas, J. C., Linn, Y. C., Hope, E. G., & Negrin, R. S. (2001). Expansion of cytotoxic CD3(+)CD56(+) cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 7(4), 216-222.

CD31 mismatching affects marrow transplantation outcome
GRUMET, F. C., Hiraki, D. D., Brown, B. W., Zehnder, J. L., Zacks, E. S., & Negrin, R. S. (2001). CD31 mismatching affects marrow transplantation outcome. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 7(9), 503-512.

Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease
Stuart, M. J., Chao, N. S., Horning, S. J., Wong, R. M., Negrin, R. S., & Goldstein, S. (2001). Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 7(10), 552-560.

Engineering hematopoietic grafts: Purified allogeneic hematopoietic stem cells plus expanded CD8(+) NK-T cells in the treatment of lymphoma
Verneris, M. R., Ito, M., Baker, E., Arshi, A., Negrin, R. S., & Shizuru, J. A. (2001). Engineering hematopoietic grafts: Purified allogeneic hematopoietic stem cells plus expanded CD8(+) NK-T cells in the treatment of lymphoma. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 7(10), 532-542.

CD2-mediated IL-12-dependent signals render human gamma delta-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies
Lopez, R. D., Xu, S., Guo, B., Negrin, R. S., & Waller, E. K. (2000). CD2-mediated IL-12-dependent signals render human gamma delta-T cells resistant to mitogen-induced apoptosis, permitting the large-scale ex vivo expansion of functionally distinct lymphocytes: implications for the development of adoptive immunotherapy strategies. BLOOD, 96(12), 3827-3837.

Resistance of ex vivo expanded CD3(+)CD56(+) T cells to Fas-mediated apoptosis
Verneris, M. R., Kornacker, M., Mailander, V., & Negrin, R. S. (2000). Resistance of ex vivo expanded CD3(+)CD56(+) T cells to Fas-mediated apoptosis. CANCER IMMUNOLOGY IMMUNOTHERAPY, 49(6), 335-345.

Effect of oral glutamine supplementation during bone marrow transplantation
Dickson, T. Mc., Wong, R. M., Negrin, R. S., Shizuru, J. A., JOHNSTON, L. J., & Stockerl-Goldstein, K. E. (2000). Effect of oral glutamine supplementation during bone marrow transplantation. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 24(2), 61-66.

Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells
Stockerl-Goldstein, K. E., Reddy, S. A., Horning, S. J., Blume, K. G., Chao, N. J., & Negrin, R. S. (2000). Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 6(5), 506-512.

A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation
Nash, R. A., Kurzrock, R., DiPersio, J., Vose, J., Linker, C., & Champlin, R. (2000). A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 6(1), 25-34.

Transplantation of highly purified CD34(+)Thy-I+ hematopoietic stem cells in patients with metastatic breast cancer
Negrin, R. S., Atkinson, K., Leemhuis, T., Hanania, E., Juttner, C., & Klein, J. (2000). Transplantation of highly purified CD34(+)Thy-I+ hematopoietic stem cells in patients with metastatic breast cancer. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 6(3), 262-271.

Use of reporter genes for optical measurements of neoplastic disease in vivo
Contag, C. H., Jenkins, D., Contag, F. R., & Negrin, R. S. (2000). Use of reporter genes for optical measurements of neoplastic disease in vivo. NEOPLASIA, 2(1-2), 41-52.

Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: No improvement in outcomes compared with single-course high-dose therapy
Hu, W. W., Negrin, R. S., Stockerl-Goldstein, K., JOHNSTON, L. J., Shizuru, J. A., & Blume, K. G. (2000). Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: No improvement in outcomes compared with single-course high-dose therapy. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 6(1), 58-69.

High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma
Alvarnas, J. C., Negrin, R. S., Horning, S. J., Hu, W. W., Long, G. D., & Chao, N. J. (2000). High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 6(3A), 352-358.

Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic tell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma
Johnston, L. J., Stockerl-Goldstein, K. E., Hu, W. W., Negrin, R. S., Hoppe, R. T., & Horning, S. J. (2000). Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic tell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 6(5A), 555-562.

Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation
Cao, T. M., Negrin, R. S., Stockerl-Goldstein, K. E., JOHNSTON, L. J., Shizuru, J. A., & Hu, W. W. (2000). Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 6(4), 387-394.

Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: Results of a prospective double-blind randomized trial
Chao, N. J., Snyder, D. S., Jain, M., Wong, R. M., Niland, J. C., & Blume, K. G. (2000). Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: Results of a prospective double-blind randomized trial. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 6(3), 254-261.

Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission
Snyder, D. S., Nademanee, A. P., O'Donnell, M. R., Parker, P. M., Stein, A. S., & Forman, S. J. (1999). Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remission. LEUKEMIA, 13(12), 2053-2058.

A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer
Hu, W. W., Long, G. D., Stockerl-Goldstein, K. E., JOHNSTON, L. J., Chao, N. J., & Blume, K. G. (1999). A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer. CLINICAL CANCER RESEARCH, 5(11), 3411-3418.

Visualizing the kinetics of tumor-cell clearance in living animals
Sweeney, T. J., Mailander, V., Tucker, A. A., Olomu, A. B., Zhang, W. S., & Contag, C. H. (1999). Visualizing the kinetics of tumor-cell clearance in living animals. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 96(21), 12044-12049.

Noninvasive assessment of tumor cell proliferation in animal models.
Edinger, M., Sweeney, T. J., Tucker, A. A., Olomu, A. B., Negrin, R. S., & Contag, C. H. (1999). Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia , 1(4), 303-310.

ISHAGE Scientific Committee Report - Assays to determine hematopoietic stem cell content in blood or marrow grafts
Verfaillie, C. M., Ploemacher, R., di Persio, J., Sutherland, R., Serke, S., & Negrin, R. (1999). ISHAGE Scientific Committee Report - Assays to determine hematopoietic stem cell content in blood or marrow grafts. CYTOTHERAPY, 1(1), 41-49.

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.
Ross, M., Schmidt, G. M., Niland, J. C., Amylon, M. D., Dagis, A. C., & Chao, N. J. (1999). Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival. Biology of blood and marrow transplantation , 5(5), 285-291.

Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation.
Dickson, T. M., Kusnierz-Glaz, C. R., Blume, K. G., Negrin, R. S., Hu, W. W., & Stockerl-Goldstein, K. E. (1999). Impact of admission body weight and chemotherapy dose adjustment on the outcome of autologous bone marrow transplantation. Biology of blood and marrow transplantation , 5(5), 299-305.

Assays to determine hematopoietic stem cell content in blood or marrow grafts.
Verfaillie, C. M., Ploemacher, R., di Persio, J., Sutherland, R., Serke, S., & Negrin, R. (1999). Assays to determine hematopoietic stem cell content in blood or marrow grafts. Cytotherapy, 1(1), 41-49.

Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: In vitro and in vivo efficacy in severe combined immunodeficiency disease mice
Hoyle, C., Bangs, C. D., Chang, P., Kamel, O., Mehta, B., & Negrin, R. S. (1998). Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: In vitro and in vivo efficacy in severe combined immunodeficiency disease mice. BLOOD, 92(9), 3318-3327.

Minimal residual disease.
Negrin, R. S. (1998). Minimal residual disease. Current opinion in hematology, 5(6), 488-493.

Engraftment of chronic myeloid leukemia in SCID mice
Hoyle, C. F., & Negrin, R. S. (1998). Engraftment of chronic myeloid leukemia in SCID mice. HEMATOLOGICAL ONCOLOGY, 16(3), 87-100.

A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation
Bernstein, S. H., Nademanee, A. P., Vose, J. M., Tricot, G., Fay, J. W., & Nash, R. A. (1998). A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. BLOOD, 91(9), 3509-3517.

Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Long, G. D., Amylon, M. D., Stockerl-Goldstein, K. E., Negrin, R. S., Chao, N. J., & Blume, K. G. (1997). Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies. Biology of blood and marrow transplantation , 3(6), 324-330.

Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model
HELLSTROMLINDBERG, E., Negrin, R., Stein, R., Krantz, S., Lindberg, G., & Greenberg, P. (1997). Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. BRITISH JOURNAL OF HAEMATOLOGY, 99(2), 344-351.

Cellular immunotherapy following autologous hematopoietic progenitor cell transplantation.
Lu, P. H., & Negrin, R. S. (1997). Cellular immunotherapy following autologous hematopoietic progenitor cell transplantation. Biology of blood and marrow transplantation , 3(3), 113-121.

Cellular immunotherapy and autologous transplantation for hematologic malignancy
Margolin, K. A., Negrin, R. S., Wong, K. K., Chatterjee, S., Wright, C., & Forman, S. J. (1997). Cellular immunotherapy and autologous transplantation for hematologic malignancy. IMMUNOLOGICAL REVIEWS, 157, 231-240.

Granulocyte colony-stimulating factor-induced comobilization of CD4(-)CD8(-) T cells and hematopoietic progenitor cells (CD34(+)) in the blood of normal donors
KUSNIERZGLAZ, C. R., Still, B. J., Amano, M., Zukor, J. D., Negrin, R. S., & Strober, S. (1997). Granulocyte colony-stimulating factor-induced comobilization of CD4(-)CD8(-) T cells and hematopoietic progenitor cells (CD34(+)) in the blood of normal donors. BLOOD, 89(7), 2586-2595.

High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices
Horning, S. J., Chao, N. J., Negrin, R. S., Hoppe, R. T., Long, G. D., & Blume, K. G. (1997). High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices. BLOOD, 89(3), 801-813.

Activated T cells and cytokine-induced CD3(+)CD56(+) killer cells
SCHMIDTWOLF, G. D., Negrin, R. S., & SCHMIDTWOLF, I. Gh. (1997). Activated T cells and cytokine-induced CD3(+)CD56(+) killer cells. ANNALS OF HEMATOLOGY, 74(2), 51-56.

Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies
KUSNIERZGLAZ, C. R., Schlegel, P. G., Wong, R. M., Schriber, J. R., Chao, N. J., & Long, G. D. (1997). Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies. JOURNAL OF CLINICAL ONCOLOGY, 15(1), 18-25.

High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma
Long, G. D., Chao, N. J., Hu, W. W., Negrin, R. S., Wong, R. M., & Blume, K. G. (1996). High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma. CANCER, 78(12), 2502-2509.

Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: Evidence for in vivo synergy
Negrin, R. S., Stein, R., Doherty, K., Cornwell, J., Vardiman, J., & Greenberg, P. L. (1996). Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: Evidence for in vivo synergy. BLOOD, 87(10), 4076-4081.

Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease.
Chao, N. J., Parker, P. M., Niland, J. C., Wong, R. M., Dagis, A., & Blume, K. G. (1996). Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease. Biology of blood and marrow transplantation , 2(2), 86-92.

Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma.
Stockerl-Goldstein, K. E., Horning, S. J., Negrin, R. S., Chao, N. J., Hu, W. W., & Blume, K. G. (1996). Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma. Biology of blood and marrow transplantation , 2(2), 76-85.

Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells
SCHMIDTWOLF, I. Gh., Lefterova, P., Johnston, V., Scheffold, C., Csipai, M., & Negrin, R. S. (1996). Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells. CELLULAR IMMUNOLOGY, 169(1), 85-90.

Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma
Knox, S. J., Goris, M. L., Trisler, K., Negrin, R., Davis, T., & Levy, R. (1996). Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma. CLINICAL CANCER RESEARCH, 2(3), 457-470.

Enrichment of allogeneic CD34+ cells and T cell depletion by percoll density gradient centrifugation
Negrin, R. S., KUSNIERZGLAZ, C., Blume, K. G., & Strober, S. (1996). Enrichment of allogeneic CD34+ cells and T cell depletion by percoll density gradient centrifugation. BONE MARROW TRANSPLANTATION, 17, S31-S33.

BUSULFAN/CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA
ODONNELL, M. R., Long, G. D., Parker, P. M., Niland, J., Nademanee, A., & Forman, S. J. (1995). BUSULFAN/CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA. JOURNAL OF CLINICAL ONCOLOGY, 13(12), 2973-2979.

THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE
Parker, P. M., Chao, N., Nademanee, A., ODONNELL, M. R., Schmidt, G. M., & Forman, S. J. (1995). THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE. BLOOD, 86(9), 3604-3609.

2 PATHWAYS OF EXOCYTOSIS OF CYTOPLASMIC GRANULE CONTENTS AND TARGET-CELL KILLING BY CYTOKINE-INDUCED CD3(+)CD56(+) KILLER-CELLS
Mehta, B. A., SCHMIDTWOLF, G. H., Weissman, I. L., & Negrin, R. S. (1995). 2 PATHWAYS OF EXOCYTOSIS OF CYTOPLASMIC GRANULE CONTENTS AND TARGET-CELL KILLING BY CYTOKINE-INDUCED CD3(+)CD56(+) KILLER-CELLS. BLOOD, 86(9), 3493-3499.

MULTIPLE CYCLES OF HIGH-DOSE CHEMOTHERAPY SUPPORTED BY HEMATOPOIETIC PROGENITOR CELLS AS TREATMENT FOR PATIENTS WITH ADVANCED MALIGNANCIES
Long, G. D., Negrin, R. S., Hoyle, C. F., KUSNIERZGLAZ, C. R., Schriber, J. R., & Chao, N. J. (1995). MULTIPLE CYCLES OF HIGH-DOSE CHEMOTHERAPY SUPPORTED BY HEMATOPOIETIC PROGENITOR CELLS AS TREATMENT FOR PATIENTS WITH ADVANCED MALIGNANCIES. CANCER, 76(5), 860-868.

ENRICHMENT OF BONE-MARROW AND BLOOD PROGENITOR (CD34(+)) CELLS BY DENSITY GRADIENTS WITH SUFFICIENT YIELDS FOR TRANSPLANTATION
Schriber, J. R., DEJBAKHSHJONES, S., KUSNIERZGLAZ, C. R., Ginzton, N., Still, B., & Strober, S. (1995). ENRICHMENT OF BONE-MARROW AND BLOOD PROGENITOR (CD34(+)) CELLS BY DENSITY GRADIENTS WITH SUFFICIENT YIELDS FOR TRANSPLANTATION. EXPERIMENTAL HEMATOLOGY, 23(9), 1024-1029.

TRANSPLANTATION OF ENRICHED AND PURGED PERIPHERAL-BLOOD PROGENITOR CELLS FROM A SINGLE APHERESIS PRODUCT IN PATIENTS WITH NON-HODGKINS-LYMPHOMA
Negrin, R. S., KUSNIERZGLAZ, C. R., Still, B. J., Schriber, J. R., Chao, N. J., & Strober, S. (1995). TRANSPLANTATION OF ENRICHED AND PURGED PERIPHERAL-BLOOD PROGENITOR CELLS FROM A SINGLE APHERESIS PRODUCT IN PATIENTS WITH NON-HODGKINS-LYMPHOMA. BLOOD, 85(11), 3334-3341.

IS NITROUS-OXIDE SAFE FOR BONE-MARROW HARVEST
Lederhaas, G., BROCKUTNE, J. G., Negrin, R. S., Riley, E., & Brodsky, J. B. (1995). IS NITROUS-OXIDE SAFE FOR BONE-MARROW HARVEST. ANESTHESIA AND ANALGESIA, 80(4), 770-772.

A NEW PREPARATORY REGIMEN FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA
Chao, N. J., Kastrissios, H., Long, G. D., Negrin, R. S., Horning, S. J., & Blume, K. G. (1995). A NEW PREPARATORY REGIMEN FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA. CANCER, 75(6), 1354-1359.

ENRICHMENT OF HUMAN HEMATOPOIETIC STEM-CELL ACTIVITY IN THE CD34(+)THY-1(+)LIN(-) SUBPOPULATION FROM MOBILIZED PERIPHERAL-BLOOD
Murray, L., Chen, B., Galy, A., Chen, S., Tushinski, R., & Tsukamoto, A. (1995). ENRICHMENT OF HUMAN HEMATOPOIETIC STEM-CELL ACTIVITY IN THE CD34(+)THY-1(+)LIN(-) SUBPOPULATION FROM MOBILIZED PERIPHERAL-BLOOD. BLOOD, 85(2), 368-378.

EFFECTS OF GRANULOCYTE-COLONY-STIMULATING FACTOR THERAPY ON IN-VITRO HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES
Nagler, A., MacKichan, M. L., Negrin, R. S., Donlon, T., & Greenberg, P. L. (1995). EFFECTS OF GRANULOCYTE-COLONY-STIMULATING FACTOR THERAPY ON IN-VITRO HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES. LEUKEMIA, 9(1), 30-39.

FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE, AND CYCLOPHOSPHAMIDE PLUS AUTOGRAFTING IN HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA
Horning, S. J., Negrin, R. S., Chao, N. J., Long, G. D., Hoppe, R. T., & Blume, K. G. (1994). FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE, AND CYCLOPHOSPHAMIDE PLUS AUTOGRAFTING IN HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA. JOURNAL OF CLINICAL ONCOLOGY, 12(12), 2552-2558.

FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 94 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE
Snyder, D. S., Negrin, R. S., ODONNELL, M. R., Chao, N. J., Amylon, M. D., & Blume, K. G. (1994). FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 94 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE. BLOOD, 84(5), 1672-1679.

GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Schriber, J. R., Chao, N. J., Long, G. D., Negrin, R. S., Tierney, D. K., & Blume, K. G. (1994). GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION. BLOOD, 84(5), 1680-1684.

A NOVEL POPULATION OF EXPANDED HUMAN CD3+CD56+ CELLS DERIVED FROM T-CELLS WITH POTENT IN-VIVO ANTITUMOR-ACTIVITY IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY
Lu, P. H., & Negrin, R. S. (1994). A NOVEL POPULATION OF EXPANDED HUMAN CD3+CD56+ CELLS DERIVED FROM T-CELLS WITH POTENT IN-VIVO ANTITUMOR-ACTIVITY IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY. JOURNAL OF IMMUNOLOGY, 153(4), 1687-1696.

GENERATION OF T-CELLS FROM CYTOKINE-MOBILIZED PERIPHERAL-BLOOD AND ADULT BONE-MARROW CD34+ CELLS
Galy, A. Hm., Webb, S., CEN, D. H., Murray, L. J., CONDINO, J., & Chen, B. P. (1994). GENERATION OF T-CELLS FROM CYTOKINE-MOBILIZED PERIPHERAL-BLOOD AND ADULT BONE-MARROW CD34+ CELLS. BLOOD, 84(1), 104-110.

PROPAGATION OF LARGE NUMBERS OF T-CELLS WITH NATURAL-KILLER-CELL MARKERS
SCHMIDTWOLF, I. Gh., Lefterova, P., Johnston, V., Huhn, D., Blume, K. G., & Negrin, R. S. (1994). PROPAGATION OF LARGE NUMBERS OF T-CELLS WITH NATURAL-KILLER-CELL MARKERS. BRITISH JOURNAL OF HAEMATOLOGY, 87(3), 453-458.

A RANDOMIZED STUDY OF ERYTHROPOIETIN AND GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) VERSUS PLACEBO AND G-CSF FOR PATIENTS WITH HODGKINS AND NON-HODGKINS-LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Chao, N. J., Schriber, J. R., Long, G. D., Negrin, R. S., CATOLICO, M., & Blume, K. G. (1994). A RANDOMIZED STUDY OF ERYTHROPOIETIN AND GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) VERSUS PLACEBO AND G-CSF FOR PATIENTS WITH HODGKINS AND NON-HODGKINS-LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION. BLOOD, 83(10), 2823-2828.

DETECTION OF TUMOR-CELLS IN PURGED BONE-MARROW AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS BY POLYMERASE CHAIN-REACTION AMPLIFICATION OF BCL-2 TRANSLOCATIONS
Negrin, R. S., & PESANDO, J. (1994). DETECTION OF TUMOR-CELLS IN PURGED BONE-MARROW AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS BY POLYMERASE CHAIN-REACTION AMPLIFICATION OF BCL-2 TRANSLOCATIONS. JOURNAL OF CLINICAL ONCOLOGY, 12(5), 1021-1027.

THE ROLE OF N-LINKED CARBOHYDRATE RESIDUES IN LYMPHOKINE-ACTIVATED KILLER CELL-MEDIATED CYTOLYSIS
Mehta, B. A., Collard, H. R., & Negrin, R. S. (1994). THE ROLE OF N-LINKED CARBOHYDRATE RESIDUES IN LYMPHOKINE-ACTIVATED KILLER CELL-MEDIATED CYTOLYSIS. CELLULAR IMMUNOLOGY, 155(1), 95-110.

MUTATIONS IN THE RAS PROTOONCOGENES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Neubauer, A., Greenberg, P., Negrin, R., Ginzton, N., & Liu, E. (1994). MUTATIONS IN THE RAS PROTOONCOGENES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES. LEUKEMIA, 8(4), 638-641.

ANALYSIS OF HUMAN HEMATOPOIETIC STEM-CELL POPULATIONS
Murray, L., DiGiusto, D., Chen, B., Chen, S., Combs, J., & Tsukamoto, A. (1994). ANALYSIS OF HUMAN HEMATOPOIETIC STEM-CELL POPULATIONS. BLOOD CELLS, 20(2-3), 364-370.

ROLE OF ETOPOSIDE (VP-16) IN PREPARATORY REGIMENS FOR PATIENTS WITH LEUKEMIA OR LYMPHOMA UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Blume, K. G., Long, G. D., Negrin, R. S., Chao, N. J., KUSNIERZGLAZ, C., & Amylon, M. D. (1994). ROLE OF ETOPOSIDE (VP-16) IN PREPARATORY REGIMENS FOR PATIENTS WITH LEUKEMIA OR LYMPHOMA UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION. BONE MARROW TRANSPLANTATION, 14, S9-S10.

PHENOTYPIC CHARACTERIZATION AND IDENTIFICATION OF EFFECTOR-CELLS INVOLVED IN TUMOR-CELL RECOGNITION OF CYTOKINE-INDUCED KILLER-CELLS
SCHMIDTWOLF, I. Gh., Lefterova, P., Mehta, B. A., Fernandez, L. P., HUHN, L. D., & Negrin, R. S. (1993). PHENOTYPIC CHARACTERIZATION AND IDENTIFICATION OF EFFECTOR-CELLS INVOLVED IN TUMOR-CELL RECOGNITION OF CYTOKINE-INDUCED KILLER-CELLS. EXPERIMENTAL HEMATOLOGY, 21(13), 1673-1679.

FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 99 PATIENTS WITH ACUTE-LEUKEMIA IN 1ST COMPLETE REMISSION
Snyder, D. S., Chao, N. J., Amylon, M. D., Taguchi, J., Long, G. D., & Blume, K. G. (1993). FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 99 PATIENTS WITH ACUTE-LEUKEMIA IN 1ST COMPLETE REMISSION. BLOOD, 82(9), 2920-2928.

EFFICIENT GENERATION AND CHARACTERIZATION OF TUMOR-CELL SUBCLONES WITH DIFFERENT ADHESION PATHWAYS INVOLVED IN CELL-LYSIS
Lefterova, P., Negrin, R., Neubauer, A., Huhn, D., Blume, K., & SCHMIDTWOLF, I. (1993). EFFICIENT GENERATION AND CHARACTERIZATION OF TUMOR-CELL SUBCLONES WITH DIFFERENT ADHESION PATHWAYS INVOLVED IN CELL-LYSIS. HAEMATOLOGICA, 78(6), 353-358.

CYCLOSPORINE, METHOTREXATE, AND PREDNISONE COMPARED WITH CYCLOSPORINE AND PREDNISONE FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE
Chao, N. J., Schmidt, G. M., Niland, J. C., Amylon, M. D., Dagis, A. C., & Forman, S. J. (1993). CYCLOSPORINE, METHOTREXATE, AND PREDNISONE COMPARED WITH CYCLOSPORINE AND PREDNISONE FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE. NEW ENGLAND JOURNAL OF MEDICINE, 329(17), 1225-1230.

THE EFFICACY OF GRANULOCYTE-COLONY-STIMULATING FACTOR FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA WITH MONOCLONAL-ANTIBODY PURGED BONE-MARROW
Schriber, J. R., Negrin, R. S., Chao, N. J., Long, G. D., Horning, S. J., & Blume, K. G. (1993). THE EFFICACY OF GRANULOCYTE-COLONY-STIMULATING FACTOR FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA WITH MONOCLONAL-ANTIBODY PURGED BONE-MARROW. LEUKEMIA, 7(10), 1491-1495.

TREATMENT OF THE ANEMIA OF MYELODYSPLASTIC SYNDROMES USING RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN COMBINATION WITH ERYTHROPOIETIN
Negrin, R. S., Stein, R., Vardiman, J., Doherty, K., Cornwell, J., & Greenberg, P. L. (1993). TREATMENT OF THE ANEMIA OF MYELODYSPLASTIC SYNDROMES USING RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN COMBINATION WITH ERYTHROPOIETIN. BLOOD, 82(3), 737-743.

USE AND TOXICITY OF THE COLONY-STIMULATING FACTORS
Schriber, J. R., & Negrin, R. S. (1993). USE AND TOXICITY OF THE COLONY-STIMULATING FACTORS. DRUG SAFETY, 8(6), 457-468.

GRANULOCYTE COLONY-STIMULATING FACTOR MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS ACCELERATE GRANULOCYTE AND PLATELET RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY
Chao, N. J., Schriber, J. R., Grimes, K., Long, G. D., Negrin, R. S., & Blume, K. G. (1993). GRANULOCYTE COLONY-STIMULATING FACTOR MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS ACCELERATE GRANULOCYTE AND PLATELET RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY. BLOOD, 81(8), 2031-2035.

BUSULFAN ETOPOSIDE - INITIAL EXPERIENCE WITH A NEW PREPARATORY REGIMEN FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE NONLYMPHOBLASTIC LEUKEMIA
Chao, N. J., Stein, A. S., Long, G. D., Negrin, R. S., Amylon, M. D., & Blume, K. G. (1993). BUSULFAN ETOPOSIDE - INITIAL EXPERIENCE WITH A NEW PREPARATORY REGIMEN FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE NONLYMPHOBLASTIC LEUKEMIA. BLOOD, 81(2), 319-323.

THE USE OF COLONY STIMULATING FACTORS IN CLINICAL BONE-MARROW TRANSPLANTATION
Negrin, R. S., & Greenberg, P. L. (1992). THE USE OF COLONY STIMULATING FACTORS IN CLINICAL BONE-MARROW TRANSPLANTATION. CURRENT OPINION IN IMMUNOLOGY, 4(5), 567-570.

DYNAMIC ASSESSMENT OF QUALITY-OF-LIFE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Chao, N. J., Tierney, D. K., Bloom, J. R., Long, G. D., Barr, T. A., & Blume, K. G. (1992). DYNAMIC ASSESSMENT OF QUALITY-OF-LIFE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION. BLOOD, 80(3), 825-830.

G-CSF AND PERIPHERAL-BLOOD PROGENITOR CELLS
Chao, N. J., Long, G. D., Negrin, R. S., Schriber, J. R., RAIMONDI, C. M., & Blume, K. G. (1992). G-CSF AND PERIPHERAL-BLOOD PROGENITOR CELLS. LANCET, 339(8806), 1410-1410.

Use of the polymerase chain reaction for the detection of tumor cell involvement of bone marrow and peripheral blood: implications for purging.
Negrin, R. S. (1992). Use of the polymerase chain reaction for the detection of tumor cell involvement of bone marrow and peripheral blood: implications for purging. Journal of hematotherapy, 1(4), 361-368.

INVITRO AND INVIVO ACTIVITY OF MURINE LYMPHOKINE-ACTIVATED KILLER-CELLS AFTER CRYOPRESERVATION
SCHMIDTWOLF, I. Gh., Aihara, M., Negrin, R. S., Blume, K. G., & Chao, N. J. (1992). INVITRO AND INVIVO ACTIVITY OF MURINE LYMPHOKINE-ACTIVATED KILLER-CELLS AFTER CRYOPRESERVATION. TRANSFUSION, 32(1), 42-45.

Therapy of hematopoietic disorders with recombinant colony-stimulating factors.
Negrin, R. S., & Greenberg, P. L. (1992). Therapy of hematopoietic disorders with recombinant colony-stimulating factors. Advances in pharmacology (San Diego, Calif.), 23, 263-296.

USE OF A SCID MOUSE HUMAN LYMPHOMA MODEL TO EVALUATE CYTOKINE-INDUCED KILLER-CELLS WITH POTENT ANTITUMOR CELL-ACTIVITY
SCHMIDTWOLF, I. Gh., Negrin, R. S., Kiem, H. P., Blume, K. G., & Weissman, I. L. (1991). USE OF A SCID MOUSE HUMAN LYMPHOMA MODEL TO EVALUATE CYTOKINE-INDUCED KILLER-CELLS WITH POTENT ANTITUMOR CELL-ACTIVITY. JOURNAL OF EXPERIMENTAL MEDICINE, 174(1), 139-149.

USE OF THE POLYMERASE CHAIN-REACTION TO MONITOR THE EFFECTIVENESS OF EX VIVO TUMOR-CELL PURGING
Negrin, R. S., Kiem, H. P., SCHMIDTWOLF, I. Gh., Blume, K. G., & Cleary, M. L. (1991). USE OF THE POLYMERASE CHAIN-REACTION TO MONITOR THE EFFECTIVENESS OF EX VIVO TUMOR-CELL PURGING. BLOOD, 77(3), 654-660.

THE STANFORD EXPERIENCE WITH HIGH-DOSE ETOPOSIDE CYTOREDUCTIVE REGIMENS AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA - PRELIMINARY DATA
Horning, S. J., Chao, N. J., Negrin, R. S., Hoppe, R. T., Kwak, L. W., & Blume, K. G. (1991). THE STANFORD EXPERIENCE WITH HIGH-DOSE ETOPOSIDE CYTOREDUCTIVE REGIMENS AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA - PRELIMINARY DATA. ANNALS OF ONCOLOGY, 2, 47-50.

IMPACT OF MARROW CYTOGENETICS AND MORPHOLOGY ON INVITRO HEMATOPOIESIS IN THE MYELODYSPLASTIC SYNDROMES - COMPARISON BETWEEN RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR (CSF) AND GRANULOCYTE-MONOCYTE CSF
Nagler, A., Binet, C., MacKichan, M. L., Negrin, R., Bangs, C., & Greenberg, P. (1990). IMPACT OF MARROW CYTOGENETICS AND MORPHOLOGY ON INVITRO HEMATOPOIESIS IN THE MYELODYSPLASTIC SYNDROMES - COMPARISON BETWEEN RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR (CSF) AND GRANULOCYTE-MONOCYTE CSF. BLOOD, 76(7), 1299-1307.

MAINTENANCE TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES USING RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR
Negrin, R. S., HAEUBER, D. H., Nagler, A., Kobayashi, Y., Sklar, J., & Greenberg, P. L. (1990). MAINTENANCE TREATMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES USING RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR. BLOOD, 76(1), 36-43.

EFFECTS OF CSFS IN PRELEUKEMIA
Greenberg, P. L., Negrin, R., & Nagler, A. (1990). EFFECTS OF CSFS IN PRELEUKEMIA. BONE MARROW TRANSPLANTATION, 6, 121-126.

EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE COLONY STIMULATING FACTOR AND GRANULOCYTE-MONOCYTE COLONY STIMULATING FACTOR ON INVITRO HEMATOPOIESIS IN THE MYELODYSPLASTIC SYNDROMES
Nagler, A., Ginzton, N., Negrin, R., Bang, D., Donlon, T., & Greenberg, P. (1990). EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE COLONY STIMULATING FACTOR AND GRANULOCYTE-MONOCYTE COLONY STIMULATING FACTOR ON INVITRO HEMATOPOIESIS IN THE MYELODYSPLASTIC SYNDROMES. LEUKEMIA, 4(3), 193-202.

Bone marrow transplantation for hematologic malignancies: the Stanford experience.
Chao, N. J., Amylon, M. D., Long, G. D., Negrin, R. S., Hoppe, R. T., & Blume, K. G. (1990). Bone marrow transplantation for hematologic malignancies: the Stanford experience. Clinical transplants, 157-163.

EFFECTS OF PROLONGED TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR
Greenberg, P., Negrin, R., Nagler, A., Vincent, M., & Donlon, T. (1990). EFFECTS OF PROLONGED TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR. INTERNATIONAL JOURNAL OF CELL CLONING, 8, 293-302.

THE USE OF HEMATOPOIETIC GROWTH-FACTORS IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES
Greenberg, P. L., Negrin, R., & Nagler, A. (1990). THE USE OF HEMATOPOIETIC GROWTH-FACTORS IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES. CANCER SURVEYS, 9(1), 199-212.

EFFECTS OF TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT HUMAN GRANULOCYTE COLONY STIMULATING FACTOR
Greenberg, P., Negrin, R., Nagler, A., Souza, L., & Donlon, T. (1990). EFFECTS OF TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT HUMAN GRANULOCYTE COLONY STIMULATING FACTOR. HEMATOPOIETIC GROWTH FACTORS IN TRANSFUSION MEDICINE, 338, 151-161.

LYMPHOKINE-ACTIVATED KILLER CELL-ACTIVITY AFTER CRYOPRESERVATION
SCHMIDTWOLF, I. Gh., Aihara, M., Negrin, R. S., Blume, K. G., & Chao, N. J. (1989). LYMPHOKINE-ACTIVATED KILLER CELL-ACTIVITY AFTER CRYOPRESERVATION. JOURNAL OF IMMUNOLOGICAL METHODS, 125(1-2), 185-189.

TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR - A PHASE I-II TRIAL
Negrin, R. S., HAEUBER, D. H., Nagler, A., Olds, L. C., Donlon, T., & Greenberg, P. L. (1989). TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR - A PHASE I-II TRIAL. ANNALS OF INTERNAL MEDICINE, 110(12), 976-984.

NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE IN ATELECTASIS
Duncan, S. R., Negrin, R. S., Mihm, F. G., Guilleminault, C., & Raffin, T. A. (1987). NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE IN ATELECTASIS. CHEST, 92(4), 621-624.